ghk-cu fda status approval 2026 Peptide Reclassification WADA's 2025 Prohibited List

WADA's 2025 Prohibited List Now in Effect | International Federation of Muaythai Associations (IFMA)

Yes, at all times, in and out of competition, under WADA category S2

Hepa Merz infusion

Variation:2 Gallons

athletes subject to testing should not use this product Side Effects, Reactions & Medical Contraindications Contraindications – Use is generally not recommended in: Known allergy or hypersensitivity to BPC‑157 or any component of the vial Pregnancy or breastfeeding (no adequate safety data) Active malignancy or history of cancer unless cleared by a specialist, due to theoretical concerns around angiogenesis and cell‑growth modulation Severe uncontrolled cardiovascular, renal, hepatic, or autoimmune disease without specialist supervision Competitive/regulated athletes subject to WADA or similar anti‑doping rules Common Side Effects and Adverse Reactions Local injection‑site reactions: redness, swelling, itching, bruising, pain Headache, dizziness or light‑headedness Nausea, stomach discomfort, diarrhea or constipation Fatigue, changes in energy or sleep disturbance Flushing or warmth sensations Because products are often unregulated, contamination or incorrect dosing may also contribute to side effects Reactions Requiring Medical Attention Patients should stop injections and seek urgent medical care (or emergency services, if severe) if they experience: Signs of a serious allergic reaction: widespread rash, hives, facial/tongue swelling, difficulty breathing Chest pain, severe shortness of breath or rapid heartbeat Severe or persistent abdominal pain, vomiting or bloody stools Sudden, unexplained swelling, rapid weight gain, or marked changes in blood pressure Any other new or worsening symptoms that feel serious or concerning Safety Note: Long‑term data is limited